Oral cancer is diagnosed through a combination of visual examination, physical palpation, tissue biopsy, and imaging scans. The process typically starts with a screening exam by a dentist or doctor who spots something unusual, then moves to a biopsy that provides the definitive answer. From the first suspicious finding to a confirmed diagnosis, the timeline can range from a few days to a couple of weeks depending on how many steps are needed.
The Clinical Exam: What Your Provider Looks For
The diagnostic process begins with a hands-on screening. Your provider visually inspects the inside of your mouth, checking your cheek lining, the floor and roof of your mouth, gums, lips, tongue, and tonsils. They’re looking for lesions, which are areas of abnormal tissue. Two types raise the most concern: leukoplakia (thick white or gray patches that can’t be scraped off and feel slightly raised with a hard surface) and erythroplakia (abnormally red patches). White patches are relatively common and only occasionally indicate cancer, but red patches carry a higher risk of being precancerous or cancerous.
Beyond looking, your provider will use their fingers to feel for lumps or bumps around your face, neck, and jaw. This palpation step matters because some tumors aren’t visible on the surface but can be felt beneath the tissue, and swollen lymph nodes in the neck can signal that cancer has spread.
Screening Dyes and Lights
Some providers use additional tools to make suspicious areas easier to see. One option is toluidine blue dye, which is painted onto lesions. Abnormal cells absorb the dye more readily than healthy tissue, highlighting areas that may be precancerous. Another approach involves rinsing with a fluorescent mouthwash and then shining a special light into the mouth. Under this light, healthy tissue appears dark while abnormal tissue glows white.
These tools are helpful but not perfect. A systematic review of autofluorescence imaging found an average sensitivity of about 78% and specificity around 66%. That means these lights catch most abnormalities but also flag some healthy tissue as suspicious. They work best as a supplement to a thorough visual and physical exam, not a replacement for biopsy.
Biopsy: The Only Way to Confirm Cancer
No screening exam or imaging scan can definitively diagnose oral cancer. That requires a biopsy, where a sample of tissue is removed and examined under a microscope by a pathologist. Several types are used depending on the situation.
- Incisional biopsy: The doctor removes a piece of the suspicious lesion, not the whole thing. The sample needs to be deep enough for a pathologist to assess whether cancer cells have invaded below the surface layer. This is the most common starting point when cancer is suspected.
- Punch biopsy: A specialized circular tool removes a small cylinder of tissue. This technique is particularly useful because it captures depth, showing how far into the tissue the abnormality extends.
- Excisional biopsy: The entire lesion is removed. This is typically reserved for small lesions where removing everything is straightforward. For larger or more complex cases, doctors prefer to start with an incisional biopsy to confirm the diagnosis before planning a bigger procedure.
- Brush biopsy: A brush is rubbed across the surface of a lesion to collect cells. Dentists sometimes use this as a first step because it’s quick and painless. However, it only samples the surface and doesn’t reach deeper tissue layers, so a positive or suspicious result still requires a traditional biopsy to confirm.
How Long Biopsy Results Take
After tissue is removed, it goes to a pathology lab for processing and analysis. Simple biopsies typically have results within two to three days. Larger or more complex cancer cases may take around five days. If the tissue requires additional steps, such as decalcification (needed when bone is involved), special stains to identify specific cell types, or a consultation between pathologists, each of those adds one to two days to the timeline.
When significant delays are expected, labs will often issue a preliminary report with a likely diagnosis and follow up later with final results once all special studies are complete. Your provider may be able to give you a verbal update before the written report is finalized.
HPV Testing and Tumor Markers
For cancers in the back of the throat (the oropharynx, including the tonsils and base of the tongue), pathologists routinely test for HPV involvement. They do this by checking for a protein called p16, which accumulates in cells when HPV’s cancer-driving proteins are active. HPV-positive oropharyngeal cancers behave differently from HPV-negative ones and generally carry a better prognosis, so this distinction affects treatment planning.
For cancers in the oral cavity itself (the front two-thirds of the tongue, gums, cheek lining, floor of the mouth), HPV plays a much smaller role. A study analyzing 281 oral squamous cell carcinoma cases found that strong p16 positivity is rare in these tumors, and p16 isn’t a reliable indicator of HPV infection in oral cavity cancers the way it is for oropharyngeal cancers.
Imaging Scans for Staging
Once a biopsy confirms cancer, imaging scans determine how far it has spread. This staging process guides treatment decisions and provides a clearer picture of what you’re dealing with.
For most oral cavity cancers, contrast-enhanced CT scanning is the primary tool. A specific technique called the “puffed cheek” method, where you inflate your cheeks with air during the scan, helps separate the soft tissues so tumors are easier to see. CT is also the preferred choice for evaluating whether cancer has reached the jawbone, using special bone-focused image processing to detect erosion.
MRI is better for cancers of the tongue and the floor of the mouth. It provides superior soft tissue detail, making it the best option for measuring how deep a tumor extends into the tongue muscle, whether it crosses the midline, and whether it has spread along nerves. Depth of invasion is a critical measurement in oral cancer staging because it directly affects the stage assignment and treatment approach.
PET-CT scans, which highlight areas of high metabolic activity throughout the body, may be used in certain situations to check for distant spread or to evaluate lymph nodes that look borderline on CT or MRI.
What Staging Tells You
Oral cancers are staged using the TNM system, which evaluates three things: the size and depth of the primary tumor (T), whether cancer has reached nearby lymph nodes (N), and whether it has spread to distant parts of the body (M). The current staging system, updated in 2018, added depth of invasion as a factor in determining the T stage for oral cavity cancers. This was a significant change because two tumors of the same surface size can be staged very differently if one has grown deeper into surrounding tissue.
Staging typically combines the biopsy findings (which reveal the cancer type, grade, and depth of invasion) with imaging results (which show the tumor’s full extent and any spread). Together, these determine whether the cancer is early stage, locally advanced, or metastatic, each of which follows a different treatment path.